Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: Implications for nitric oxide pathways

Pain

Volumn 87, Issue 2, 2000, Pages 201-211

  Larson, Alice A ^a   Giovengo, Susan L ^b   Russell, I Jon ^c   Michalek, Joel E ^c  

^a Graduate Program in Neuroscience   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Allodynia; Amino acids; Cerebrospinal fluid; Fibromyalgia syndrome; Nitric oxide; Pain

Indexed keywords

ARGININE; ASPARAGINE; CITRULLINE; EXCITATORY AMINO ACID; GLUTAMINE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; SUBSTANCE P; TAURINE;

ADULT; AGED; ALLODYNIA; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; MALE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; ASPARAGINE; EXCITATORY AMINO ACIDS; FEMALE; FIBROMYALGIA; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; N-METHYLASPARTATE; NITRIC OXIDE; PAIN; PAIN MEASUREMENT; SIGNAL TRANSDUCTION;

EID: 0034255082     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00284-0     Document Type: Article

References (79)

1. Aanonsen L.M., Wilcox G.L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J Pharmacol Exp Ther. 243:1987;9-19.
2. Aanonsen L.M., Lei S., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1990;309-321.
3. Albrecht J. Roles of neuroactive amino acids in ammonia neurotoxicity. J Neurosci Res. 51:1988;133-138.
4. Almay B.G., Johansson F., von Knorring L., Greves P.L., Terenius L. Substance P in CSF of patients with chronic pain syndromes. Pain. 33:1988;3-9.
5. Aoki E., Semba R., Mikoshiba K., Kashiwamata S. Predominant localization in glial cells of free L-arginine. Immunocytochemical evidence. Brain Res. 547:1991;190-192.
6. Arroyo J.F., Cohen M.L. Abnormal response to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 20:1993;1925-1931.
7. Baker A.J., Zornow M.H., Grafe M.R., Scheller M.S., Skilling S.R., Smullin D.H., Larson A.A. Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits. Stroke. 22:1991;666-673.
8. Battaglia G., Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurol. 277:1988;302-312.
9. Budai D., Wilcox G.L., Larson A.A. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci Lett. 135:1992;265-268.
10. Campbell J.N., Meyer R.A. Sensitization of unmyelinated nociceptive afferents in monkey varies with skin type. J Neurophysiol. 49:1983;98-110.
11. Campbell S.M., Clark S., Tindall E.A., Forehand M.E., Bennett R.M. Clinical characteristics of fibrositis. I. A "blinded", controlled study of symptoms and tender points. Arthritis Rheum. 26:1983;817-824.
12. Cathey M.A., Wolfe F., Kleinheksel S.M. Functional ability and work status in patients with fibromyalgia. Arthritis Care Res. 1:1988;85-98.
13. Coderre T.J., Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci. 12:1992;3671-3675.
14. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
15. Cotman C.W., Monaghan D.T., Ottersen O.P., Mathison J.S. Anatomical organization of EAA receptors and their pathways. Trends Neurosci. 10:1987;273-280.
16. Danysz W., Wroblewski J.T., Booker G., Costa E. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res. 479:1989;270-276.
17. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA. 85:1988;7820-7824.
18. Dougherty P.M., Willis W.D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain. 47:1991;85-93.
19. Duggan A.W., Hendry I.A., Morton C.R., Hutchinson W.D., Zhao Z.Q. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res. 451:1988;261-273.
20. Fischer A.A. Pressure threshold measurement for the diagnosis of myofascial pain and evaluation of treatment results. Clin J Pain. 2:1987;207-214.
21. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu Rev Physiol. 57:1995;683-706.
22. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messengers in the brain. Nature. 336:1988;385-388.
23. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain. 58:1994;185-193.
24. Giovengo S.L., Russell I.J., Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 26:1999;1564-1569.
25. Goldenberg D.L. Fibromyalgia syndrome. J Am Med Assoc. 257:1987;2782-2787.
26. Grima G., Benz B., Do K.Q. Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells. Eur J Neurosci. 9:1997;2248-2258.
27. Grima G., Cuenod M., Pfeiffer S., Mayer B., Do K.Q. Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis: involvement of a glial-neuronal arginine transfer. J Neurochem. 71:1998;2139-2144.
28. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
29. Helke C.J., Charlton C.G., Wiley R.G. Studies on the cellular localization of spinal cord substance P receptors. Neuroscience. 19:1986;523-533.
30. Hornfeldt C.S., Smullin D.H., Schamber C.D., Sun X., Larson A.A. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sci. 50:1992;1925-1934.
31. Jansen K.L.R., Faull R.L.M., Dragunow M., Waldvogel H. Autoradiographic localization of NMDA, quisqualate and kainic acid receptors in human spinal cord. Neurosci Lett. 108:1990;53-57.
32. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 325:1987;529-531.
33. King A.E., Lopez-Garcia J.A. Excitatory amino acid receptor-mediated neurotransmission from cutaneous afferents in rat dorsal horn in vitro. J Physiol. 472:1993;443-457.
34. Kleckner N.W., Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. Science. 241:1988;835-837.
35. 3H]MK-801 binding is different in mouse brain and spinal cord: effect of glycine and glutamate. Eur J Pharmacol. 324:1997;117-123.
36. Kuraishi Y., Hirota N., Sato Y., Hanashima N., Takagi H., Satoh M. Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ. Neuroscience. 30:1989;241-250.
37. Larson A.A., Beitz A.J. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors. J Neurosci. 8:1988;3822-3826.
38. Lehmann A., Hagberg H., Hamberg A. A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation. Neurosci Lett. 52:1984;347-350.
39. Liu H., Wang H., Sheng M., Jan L.Y., Jan Y.N., Basbaum A.I. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci USA. 91:1994;8383-8387.
40. Meller S.T., Gebhart G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 52:1993;127-136.
41. Meller S.T., Dykstra C., Gebhart G.F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for the N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol. 214:1992;93-96.
42. Meller S.T., Pechman P.S., Gebhart G.F., Maves T.J. Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience. 50:1992;7-10.
43. Norenberg M.D., Hernandez A.M. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 161:1979;303-310.
44. Nyberg F., Liu Z., Lind C., Thornwall M., Ordeberg G. Enhanced CSF levels of substance P in patients with painful arthrosis but not in patients with pain from herniated lumbar discs. J Musculoskel Pain. 3:(Suppl 1):1995;2.
45. Okano K., Kuraishi Y., Satoh M. Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats. Biol Pharm Bull. 16:1993;861-865.
46. Olofsson C., Ekblom A., Ekman-Ordeberg G., Irestedt L., Nyberg F., Ungerstedt U., Wiklund P. Increased cerebrospinal fluid concentration of aspartate but decreased concentration of nitric oxide breakdown products in women experiencing visceral pain during active labour. NeuroReport. 8:1997;995-998.
47. Quimby L.G., Block S.R., Gratwick G.M. Fibromyalgia: generalized pain intolerance and manifold symptom reporting. J Rheumatol. 15:1988;1264-1270.
48. Radhakrishnan V., Henry J.L. L-NAME blocks responses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn. NeuroReport. 4:1993;323-326.
49. Radhakrishnan V., Yashpal K., Hui-Chan C.W., Henry J.L. Implication of a nitric oxide synthase mechanism in the action of substance P: L-NAME blocks thermal hyperalgesia induced by endogenous and exogenous substance P in the rat. Eur J Neurosci. 7:1995;1920-1925.
50. Raigorodsky G., Urca G. Involvement of NMDA receptors in nociception and motor control in the spinal cord of the mouse: behavioral, pharmacological and electrophysiological evidence. Neuroscience. 36:1990;601-610.
51. Raja S., Campbell J.N., Meyer R.A. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain. 107:1984;1179-1188.
52. Russell I.J., Orr M.D., Michalek J.E., Nyberg F., Ericksson U. Substance P (SP), SP endopeptidase activity, and SP N-terminal peptide fragment (SP1-7) in fibromyalgia syndrome cerebrospinal fluid. J Musculoskel Pain. 3:(Suppl 1):1993;51995.
53. Russell I.J., Orr M.D., Littman B., Vipraio G.A., Alboukrek D., Michalek J.E., Lopez Y., MacKillip F. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37:1994;1593-1601.
54. Salt T.E. Modulation of NMDA receptor-mediated responses by glycine and D-serine in the rat thalamus in vivo. Brain Res. 481:1989;403-406.
55. Schneider S.P., Perl E.R. Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: correlation with location and excitatory input. Brain Res. 360:1985;339-343.
56. Scudds R.A., Rollman G.B., Harth M., McCain G.A. Pain perception and personality measures as discriminators in the classification of fibrositis. J Rheumatol. 14:1987;563-569.
57. Segawa T., Nomura Y., Shimazaki I. Possible involvement of calmodulin in modulatory role of taurine in rat cerebral beta-adrenergic neurons. Prog Clin Biol Res. 179:1985;321-330.
58. Serrano J.S., Serrano M.I., Guerrero M.R., Ruiz R., Polo J. Antinociceptive effect of taurine and its inhibition by naloxone. Gen Pharmacol. 21:1990;333-336.
59. Skilling S.R., Smullin D.H., Larson A.A. Extracellular amino acid concentration in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem. 51:1988;127-132.
60. Skilling S.R., Smullin D.H., Larson A.A. Differential effects of C- and N-terminal substance P metabolites on the apparent release of amino acid neurotransmitters from the spinal cord: potential role in nociception. J Neurosci. 10:1990;1309-1318.
61. Sorkin L.S., Westlund K.N., Sluka K.A., Dougherty P.M., Willis W.D. Neural changes in acute arthritis in monkeys. IV. Time course of amino acid release into the lumbar dorsal horn. Brain Res Rev. 17:1992;39-50.
62. Springer J.E., Gwag B.J., Sessler F.M. Central administration of the excitotoxin N-methyl-D-aspartate increases nerve growth factor mRNA in vivo. Neurotoxicology. 15:1994;483-490.
63. Stevens B.R., Kakuda D.K., Yu K., Waters M., Vo C.B., Raizada M.K. Induced nitric oxide synthesis is dependent on induced alternatively spliced CAT-2 encoding L-arginine transport in brain astrocytes. J Biol Chem. 271:1996;24017-24022.
64. Tsigos C., Diemel L.T., Tomlinson D.R., Young R.J. Cerebrospinal fluid levels of substance P and calcitonin gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy. Clin Sci. 84:1993;305-311.
65. Vaeroy H., Helle R., Forre O., Kass E., Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 32:1988;21-26.
66. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Annu Rev Pharm Toxicol. 21:1981;165-204.
67. Weiler C.T., Nystrom B., Hamberger A. Characteristics of glutamine vs. glutamate transport in isolated glia and synaptosomes. J Neurochem. 32:1979;559-565.
68. Welin M., Bragee B., Nyberg F., Kristiansson M. Elevated substance P levels are contrasted by a decrease in met-enkephalin-arg-phe levels in CSF from fibromyalgia patients. J Musculoskel Pain. 3:(Suppl 1):1995;4.
69. Westlund K.N., McNeill D.L., Coggeshall R.E. Glutamate immunoreactivity in rat dorsal root axons. Neurosci Lett. 96:1988;13-17.
70. White K.P., McCain G.A., Tunks E. Effects of changing the painful stimulus upon dolorimetry scores in patients with fibromyalgia. J Musculoskel Pain. 1:1993;43-58.
71. Wolfe J. Fibromyalgia. Bellamy N. Prognosis in the rheumatic diseases. 1991;321-332 Klumer Academic, London.
72. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombadier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C.M., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., McGain G.A., Reynolds W.J., Romano T.J., Russell I.J., Sheon R.P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 33:1990;160-172.
73. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38:1995;19-28.
74. Woodley S.J., Kendig J.J. Substance P and NMDA receptors mediate a slow nociceptive ventral root potential in neonatal rat spinal cord. Brain Res. 559:1991;17-21.
75. Woolf C.J. Evidence for a central component of postinjury pain hypersensitivity. Nature. 308:1983;686-688.
76. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
77. Yamada K. Role of nitric oxide in learning and memory processes. Nippon Yakurigaku Zassi. 111:1998;87-96.
78. Yunus M.B., Kalyan-Raman U.P., Masi A.T., Aldag J.C. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol. 16:1989;97-101.
79. Zochodne D.W., Murray M., Nag S., Riopelle R.J. A segmental chronic pain syndrome in rats associated with intrathecal infusion of NMDA: evidence for selective action in the dorsal horn. Can J Neurol Sci. 21:1994;24-28.